FHTX Competitors & Alternatives
Compare Foghorn Therapeutics Inc with similar stocks in the same industry
Biotechnology
FHTX
Main Stock$2.01
Tradestie Score
60
Market Cap
$278.69M
Revenue Growth
1.1%
Analyst Upside
+107.3%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$7.45
|
$170.45M | - | 42 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.50
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.89
|
$154.27M | - | 60 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$3.18
|
$153.02M | - | 47 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.54
|
$133.50M | - | 63 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.60
|
$114.01M | - | 63 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$22.20
|
$110.20M | - | 57 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$3.60
|
$85.47M | - | 55 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.02
|
$84.52M | - | 42 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.35
|
$67.94M | - | 60 | Compare |
More FHTX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry